Sustainable Investing
1 minute read
About six weeks into the new year, and the investment narrative has already started to take shape. Many investors seem to believe that the Federal Reserve and other global central banks will start to lower interest rates, but they remain on edge about the possibility that geopolitical tensions, supply chain disruptions and strong growth data might cause a fresh surge in inflation that disrupts those plans. We’re watching all of those developments, as the start of the year doesn’t always set the tone for what follows.
Within equity markets, the technology and healthcare sector are two of the best performing sectors globally. And in the corporate sphere, merger and acquisition activity is already doubling last year’s pace.
So which trends are here to stay?
Here's the good news: we think the inflation worries that have marked the first few weeks of 2024 will continue to fade away. That might not be obvious from the news, as inflation expectations embedded in the bond market are at the highest level since October. December’s CPI report showed larger price increases than economists expected. Meanwhile, supply chain disruptions due to conflict in the Red Sea (and, to a lesser extent, water levels in the Panama Canal) have sent shipping costs soaring. Freight rates from Shanghai to Los Angeles have doubled since December.
But we are watching the bigger picture. For one, shipping costs are still 70% lower than their COVID-era peaks, and imported goods only make up only 10% of U.S. consumer spending. That means higher import costs have a muted effect on the prices in the U.S.
More importantly, we believe that there is still more disinflation to come from both shelter prices and the labor market. The Federal Reserve’s index for real-time rent is plunging at its fastest pace on record. Further, labor markets have normalized. The Labor Department’s quits rate and job openings metrics, which measure both labor demand and wage pressure, are more or less at their pre-pandemic levels.
Putting it all together, we believe that the worries about an inflation resurgence are misplaced, at least for 2024.
The technology and healthcare sectors are rallying, and we expected that trend to continue. For both, it all comes down to earnings, and long-term trends appear supportive. Last year, the healthcare sector posted its first year on record of negative earnings growth because of the surge in COVID related spending that had dramatically expanded their profits in 2021 and 2022 came to an end.
While analysts expect two more quarters of negative growth for the sector, it seems the worst is over, and we would rather focus on the potential inflection point.
The still nascent expansion of GLP-1 weight loss drugs can potentially drive upside for healthcare. An increase in M&A activity and continued drug innovation could present additional tailwinds.
Technology has already emerged from its own earnings recession, and we expect the sector to generate mid-teens earnings growth through 2025. The global artificial intelligence trend will be a major factor here, and the two largest tech stocks by market cap are leaders in AI. Nvidia, which makes the chips that power AI, and Microsoft, which may possess the clearest vision of how to integrate AI with existing products to drive pricing power, make up over one third of the S&P 500 technology sector.
Another trend that we expect to continue is increased merger and acquisition activity. With less macroeconomic uncertainty, lower interest rates and higher equity valuations, management teams appear to be more comfortable making deals. The year-to-date total of nearly $180 billion in announced deals as of January 25, 2024 is almost double last year’s pace.
Notable deals include the $33 billion software tie-up between Synopsys and ANSYS, BlackRock’s purchase of Global Infrastructure Management, and Sekisui House’s acquisition of MDC Holdings, which will create the fifth largest homebuilder in the U.S. More M&A activity could also be a positive for private equity managers and owners of closely held businesses that have had a hard time monetizing investments over the past few years.
No matter which trends fade and which ones endure, we think that the macroeconomic backdrop of stable inflation, declining policy rates, and solid corporate earnings growth paints a constructive backdrop for multi-asset portfolios.
We can help you navigate a complex financial landscape. Reach out today to learn how.
Contact usLEARN MORE About Our Firm and Investment Professionals Through FINRA BrokerCheck
To learn more about J.P. Morgan’s investment business, including our accounts, products and services, as well as our relationship with you, please review our J.P. Morgan Securities LLC Form CRS and Guide to Investment Services and Brokerage Products.
JPMorgan Chase Bank, N.A. and its affiliates (collectively "JPMCB") offer investment products, which may include bank-managed accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC ("JPMS"), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPMorgan Chase & Co. Products not available in all states.
Please read the Legal Disclaimer for key important J.P. Morgan Private Bank information in conjunction with these pages.
Bank deposit products, such as checking, savings and bank lending and related services are offered by JPMorgan Chase Bank, N.A. Member FDIC.
Not a commitment to lend. All extensions of credit are subject to credit approval.